ArticleJournal for immunotherapy of cancer2022

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors.

Sven Borchmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.